Melbourne Clinical Trials

The Weight Loss Study

The study drug is a potential new treatment for weight loss

0 nights
2 full-day visits, 4 half-day visits + 3 phone calls, 36 days at-home dosing, 1 follow-up visits

The study medication is a potential new treatment that is hoped to cause weight loss by mimicking the changes that happen in the intestinal microbiome as observed in people who have
undergone gastric bypass surgery. The study drug has previously been shown to be safe and well tolerated in another clinical trial.

The study medication is administered as an oral capsule.
Participants will take 2 doses per day for 42 days. On 6 days, the doses will be administered at the clinic. On all other days, participants will take the doses at home (called at-home-dosing).

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!


Biological Sex Healthy males and females
Age 18 - 60 years old, inclusive
BMI 30 - 45 kg/m²
Smoking History Non-smokers or smoking less than 5 cigarettes per/week